SystImmune Begins Global Trial for Iza-Bren in Breast Cancer, Triggers $250M Milestone from BMS Read more
Cidara’s CD388 Receives FDA Breakthrough Therapy Designation for Flu Prevention in High-Risk Read more
FDA Approves Boehringer Ingelheim’s JASCAYD as First PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis Read more
LEAN Cell & Gene Summit Series Expands Following Successful Boston Debut Next event to take place in National Harbor, MD, November 6, 2025 Read more